Review



human dermal microvascular endothelial cells hmvec  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC human dermal microvascular endothelial cells hmvec
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Dermal Microvascular Endothelial Cells Hmvec, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 86 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc12862960-31-0-10?v=ATCC
    Average 95 stars, based on 86 article reviews
    human dermal microvascular endothelial cells hmvec - by Bioz Stars, 2026-07
    95/100 stars

    Images

    1) Product Images from "The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge"

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    Journal: Clinical Science (London, England : 1979)

    doi: 10.1042/CS20256682

    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Figure Legend Snippet: (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Techniques Used: Activity Assay

    (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Figure Legend Snippet: (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Techniques Used: Expressing, Control

    Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.
    Figure Legend Snippet: Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.

    Techniques Used: Control, CCK-8 Assay, Migration, Phospho-proteomics, Expressing



    Similar Products

    95
    ATCC human dermal microvascular endothelial cells hmvec
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Dermal Microvascular Endothelial Cells Hmvec, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc12862960-31-0-10?v=ATCC
    Average 95 stars, based on 1 article reviews
    human dermal microvascular endothelial cells hmvec - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    90
    Lonza human microvascular endothelial cells-dermal (hmvec-d)
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Microvascular Endothelial Cells Dermal (Hmvec D), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pm39985455-36-0-5?v=Lonza
    Average 90 stars, based on 1 article reviews
    human microvascular endothelial cells-dermal (hmvec-d) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza primary human dermal microvascular endothelial cells (hmvec-d)
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Primary Human Dermal Microvascular Endothelial Cells (Hmvec D), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc11792520-44-0-10?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human dermal microvascular endothelial cells (hmvec-d) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza human dermal microvascular endothelial cells (hmvecs)
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Human Dermal Microvascular Endothelial Cells (Hmvecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pm39210776-84-0-14?v=Lonza
    Average 90 stars, based on 1 article reviews
    human dermal microvascular endothelial cells (hmvecs) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza human dermal microvascular endothelial cells hmvec-ds
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Human Dermal Microvascular Endothelial Cells Hmvec Ds, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc11537974-314-0-6?v=Lonza
    Average 90 stars, based on 1 article reviews
    human dermal microvascular endothelial cells hmvec-ds - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza human dermal microvascular lymphatic endothelial cells isolated from adult donors hmvec-dlyad
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Human Dermal Microvascular Lymphatic Endothelial Cells Isolated From Adult Donors Hmvec Dlyad, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc11317532__42003_2024_6675_MOESM8_ESM-55-15-17?v=Lonza
    Average 90 stars, based on 1 article reviews
    human dermal microvascular lymphatic endothelial cells isolated from adult donors hmvec-dlyad - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza human dermal microvascular lymphatic endothelial cells hmvec-dlyad
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Human Dermal Microvascular Lymphatic Endothelial Cells Hmvec Dlyad, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pmc11317532-413-9-11?v=Lonza
    Average 90 stars, based on 1 article reviews
    human dermal microvascular lymphatic endothelial cells hmvec-dlyad - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Lonza human dermal microvascular endothelial cells (hmvec-d) from neonate foreskin
    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human <t>microvascular</t> <t>endothelial</t> cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.
    Human Dermal Microvascular Endothelial Cells (Hmvec D) From Neonate Foreskin, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hmvec/pm38286222-78-7-9?v=Lonza
    Average 90 stars, based on 1 article reviews
    human dermal microvascular endothelial cells (hmvec-d) from neonate foreskin - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Activity Assay

    (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Expressing, Control

    Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Control, CCK-8 Assay, Migration, Phospho-proteomics, Expressing

    Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human microvascular endothelial cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.

    Journal: Microbiology Spectrum

    Article Title: Transendothelial migration of the Lyme disease spirochete involves spirochete internalization as an intermediate step through a transcellular pathway that involves Cdc42 and Rac1

    doi: 10.1128/spectrum.02221-24

    Figure Lengend Snippet: Transendothelial migration of B. burgdorferi in Transwell chambers. (A) To study B. burgdorferi transmigration, Transwell chambers were seeded with hMVEC-d or hTERT cells until a tight monolayer was formed (<4% albumin diffusion). The upper chamber was infected with 3 × 10 5 spirochetes; after 20 h of infection, we counted the spirochetes in both the upper and lower chambers (either manually or by flow cytometry) and calculated the percentage of total transmigrated spirochetes (lower chamber). ( B, C ) The graphs show the percentage (mean ± SD) of B. burgdorferi that had transmigrated through human microvascular endothelial cells as determined by counting spirochetes in both the upper and lower chamber by flow cytometry. The data represent the mean of % transmigration ±SD of three independent experiments performed in quadruplicate and analyzed for significance using the Mann–Whitney test. NI denotes the non-infectious strain GCB705 (B31-A + pTM61 gent,gfp, see ), and WT indicates GCB726. ( D ) Evaluation of B. burgdorferi transendothelial migration in hTERT treated with AKB-9785. The complete chamber was treated with 5 µM AKB9785 for the duration of the assay. The upper chamber was infected with 3 × 10 5 spirochetes, and the percentage of total transmigrated spirochete was assessed by counting in a Petroff–Hausser chamber and dark-field microscopy after 20 h of infection. The data represent the mean % transmigration ±SD of three independent experiments performed in quadruplicate; non-parametric ANOVA was performed to compare the control cells with the treated cells using the Kruskal–Wallis post-test (ns = not significant). ( E ) Demonstration of the effectiveness of AKB-9785 to lock intercellular junctions in hTERT cells. Ly 294002 at 40 µM was used to disrupt the monolayer, and AKB-9785 was used to lock intercellular junctions and preserve monolayer integrity, which was assessed using an albumin diffusion assay: 10 μg of 555-Alb was added to the upper chamber at 16 h, and the reading was carried out at the final point (20 h). The graph represents the mean ± SD of three experiments, with 1–4 samples for each experimental condition. Statistics were evaluated with the Kruskal–Wallis test and Dunn’s multiple comparison; P < 0.05 was considered significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns = not significant.

    Article Snippet: Primary human dermal microvascular endothelial cells (hMVEC-d) were purchased from Lonza (CC-2543), grown in Basal Medium (EBM-2) (CC-3156, Lonza) complete media (with supplements EGMTM-2 SingleQuotsTM Supplements [CC-4176, Lonza]) at 37°C under 5% CO 2 and used before passage five. hTERT-immortalized dermal microvascular endothelial cell, neonatal (CRL4060, ATCC), was used. hTERT was cultured in Vascular Cell Basal Medium (VCBM) (PCS-100-030, ATCC) with the microvascular endothelial cell growth kit-BBE (PCS-110-040, ATCC) +0.5 μg/mL puromycin (P8833, Sigma-Aldrich) according to the manufacturer’s instruction.

    Techniques: Migration, Transmigration Assay, Diffusion-based Assay, Infection, Flow Cytometry, MANN-WHITNEY, Microscopy, Control, Comparison